Intraoperative continuous hemofiltration for metabolic management in acute aortoiliac occlusion

Journal of Clinical Anesthesia

Volumn 10, Issue 7, 1998, Pages 599-602

  Van Der Hoven, B ^a,b   Van Der Spoel, J I ^a,b   Scheffer, G J ^a,b   Spoelder, E M ^a,b   Rauwerda, J A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Surgical Intensive Care ^*

Author keywords

Aortic occlusion, acute; Hemofiltration, venovenous; Ischemia reperfusion injury; Leriche's syndrome; Renal failure, acute; Renal replacement therapy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DETERIORATION; ELECTROLYTE BALANCE; HEMOFILTRATION; HUMAN; HYPERKALEMIA; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; LERICHE SYNDROME; MALE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REPERFUSION INJURY;

ACUTE DISEASE; AORTA; CREATININE; HEMOFILTRATION; HUMANS; ILIAC ARTERY; INTRAOPERATIVE CARE; LERICHE'S SYNDROME; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; POTASSIUM; REPERFUSION INJURY;

EID: 0032213803     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(98)00086-5     Document Type: Article

References (20)

1. Bradbury AW, Stonebridge PA, John TG, Ruckley CY, Jenkins AM, Murie JA: Acute thrombosis of the non-aneurysmal abdominal aorta. Eur J Vasc Surg 1993;7:320-3.
2. Dossa CD, Shepard AD, Reddy DJ, et al: Acute aortic occlusion. A 40-year experience. Arch Surg 1994;129:603-8.
3. Feinfeld DA, Cheng JT, Beysolow TD, Briscoe AM: A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clin Nephrol 1992;38:193-5.
4. Wu AH, Laios I, Green S, et al: Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for renal failure. Clin Chem 1994;40:796-802.
5. Better OS, Rubinstein I, Winaver J: Recent insights into the pathogenesis and early management of the crush syndrome. Semin Nephrol 1992;12:217-22.
6. Better OS, Stein JH: Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990;322:825-9.
7. Sinert R, Kohl L, Rainone T, Scalea T: Exercise-induced rhabdomyolysis. Ann Emerg Med 1994;23:1301-6.
8. Wakabayashi Y, Kikuno T, Ohwada T, Kikawada R: Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Intensive Care Med 1994;20:109-12.
9. Bellomo R, Ronco C: Acute renal failure in the intensive care unit: which treatment is the best? In: Bellomo R, Ronco C (eds): Acute Renal Failure in the Critically III. Update in Intensive Care and Emergency Medicine, vol. 20. Heidelberg: Springer-Verlag, 1995: 385-407.
10. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-40.
11. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-6.
12. Heering P, Morgera S, Schmitz FJ, et al: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997;23:288-96.
13. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P: Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995;21: 169-76.
14. Bellomo R: Continuous hemofiltration as blood purification in sepsis. New Horizons 1995;3:732-7.
15. Grootendorst AF, van Saase JL: Blood purification by hemofiltration in septic shock and multiple organ dysfunction patients. In: Bellomo R, Ronco C (eds): Acute Renal Failure in the Critically Ill. Update in Intensive Care and Emergency Medicine, vol. 20. Heidelberg: Springer-Verlag, 1995;311-23.
16. Berns JS, Cohen RM, Rudnick RM: Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis [Letter]. Am J Nephrol 1991; 11:73.
17. Boyce N, Bellomo R: Tumor necrosis factor and continuous arteriovenous hemodialysis [Letter]. Crit Care Med 1993;21:1806-7.
18. Byrick RJ, Goldstein MB, Wong PY: Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med 1992;20:1483-6.
19. Ronco C, Bellomo R: Complications of continuous renal replacement therapies. In: Ronco C, Bellomo R (eds): Critical Care Nephrology. Amsterdam: Kluwer Academic Publishers, 1998:1351-5.
20. Buckmaster JN, Davies AR: Guidelines for drug dosing during continuous renal replacement therapy. In: Ronco C, Bellomo R (eds): Critical Care Nephrology. Amsterdam: Kluwer Academic Publishers, 1988:1327-33.